Conference
Final results of a phase II study of voreloxin in women with platinum-resistant ovarian cancer.
Authors
Hirte HW; McGuire WP; Edwards RP; Husain A; Hoskins P; Michels JE; Matulonis U; Sexton C; Fox JA; Michelson G
Volume
28
Pagination
pp. 5002-5002
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2010
DOI
10.1200/jco.2010.28.15_suppl.5002
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X